Board MeetingOutcome of Board Meeting
Alivus Life Sciences reports Q3 financial results: Revenue from operations hit ₹672.89 Cr, with a profit of ₹150.26 Cr.
Alivus Life Sciences LimitedALIVUS · Filed with the exchange
For the nine months ending Dec 31, 2025, revenue reached ₹1862.72 Cr and profit stood at ₹401.82 Cr.
No comments yet. Be the first.